BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

As Viagra Goes Off Patent, Pfizer Inc. (PFE) Staff at Plant Remain Cautious


6/21/2013 7:23:12 AM

Hey, Pfizer's hiring! (Isn’t it tempting?)

It was the drug that launched a thousand quips. It not only propelled Pfizer into the public consciousness but put the company’s Irish headquarters and production facility at Ringaskiddy in Cork Harbour on the map internationally. Some 15 years on from its launch, Viagra is about to come off patent, opening up the market to generic copies. The mood among Pfizer’s workforce involved in the manufacture of the drug’s active pharmaceutical ingredient (API) sildenafil, in Ringaskiddy, is cautious. Part of the reason for this caution – as opposed to outright pessimism – is the fact that, despite its headline grabbing profile as the Pfizer Riser, Viagra was never as dominant a drug in Ringaskiddy’s product portfolio as it was in the public consciousness.

Don’t forget, Pfizer's hiring! (We know you can’t resist.)


Read at Irish Times
Read at International Business Times
Read at AOL

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES